News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Iovance Biotherapeutics, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
2 Bay Area Biotechs That Jumped While Its Peers Cratered
Since Friday, the stock market has been volatile, to say the least.
February 7, 2018
·
2 min read
·
Mark Terry
Biotech Bay
3 Under-the-Radar Bay Area Biotechs That Could Double in 2018
Biotech stocks are generally viewed as highly volatile. Of course, along with volatility comes the possibility for huge upside rewards.
October 18, 2017
·
2 min read
·
Mark Terry
Business
Lion Biotech Raises Approximately $100 Million and Names a New CEO
June 6, 2016
·
2 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024
February 22, 2024
·
6 min read
Biotech Bay
Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock
February 20, 2024
·
5 min read
FDA
Melanoma Research Alliance Applauds FDA Approval of First Cellular Therapy in Melanoma
February 16, 2024
·
2 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 16, 2024
February 16, 2024
·
6 min read
Biotech Bay
Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024
February 16, 2024
·
6 min read
Policy
Iovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA Accelerated Approval for Advanced Melanoma
February 16, 2024
·
17 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Jan 19, 2024
January 19, 2024
·
6 min read
Biotech Bay
Iovance Biotherapeutics Announces Clinical Program Update for LN-145 in Non-Small Cell Lung Cancer
December 27, 2023
·
8 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - December 22, 2023
December 22, 2023
·
6 min read
Biotech Bay
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - November 17, 2023
November 17, 2023
·
6 min read
